| Term | Count | % | | TREATMENT FAILURE | 5910 | 7.16% |
| DRUG INEFFECTIVE | 3146 | 3.81% |
| EYE IRRITATION | 2399 | 2.91% |
| FATIGUE | 2187 | 2.65% |
| INTRAOCULAR PRESSURE INCREASED | 1831 | 2.22% |
| HEADACHE | 1741 | 2.11% |
| EYE PAIN | 1723 | 2.09% |
| DYSPNOEA | 1591 | 1.93% |
| DEATH | 1587 | 1.92% |
| VISION BLURRED | 1582 | 1.92% |
| DIZZINESS | 1562 | 1.89% |
| DIARRHOEA | 1540 | 1.87% |
| NAUSEA | 1513 | 1.83% |
| OFF LABEL USE | 1498 | 1.82% |
| OCULAR HYPERAEMIA | 1437 | 1.74% |
| FALL | 1376 | 1.67% |
| CATARACT | 1362 | 1.65% |
| GLAUCOMA | 1335 | 1.62% |
| ASTHENIA | 1237 | 1.50% |
| PAIN | 1235 | 1.50% |
| HYPERSENSITIVITY | 1157 | 1.40% |
| RASH | 995 | 1.21% |
| MALAISE | 989 | 1.20% |
| VISUAL IMPAIRMENT | 989 | 1.20% |
| PNEUMONIA | 951 | 1.15% |
| PRURITUS | 925 | 1.12% |
| WEIGHT DECREASED | 918 | 1.11% |
| CONDITION AGGRAVATED | 903 | 1.09% |
| ARTHRALGIA | 889 | 1.08% |
| PAIN IN EXTREMITY | 885 | 1.07% |
| COUGH | 859 | 1.04% |
| VOMITING | 832 | 1.01% |
| HYPERTENSION | 823 | 1.00% |
| EYE PRURITUS | 785 | 0.95% |
| DRUG HYPERSENSITIVITY | 755 | 0.92% |
| VISUAL ACUITY REDUCED | 729 | 0.88% |
| CONSTIPATION | 706 | 0.86% |
| DRY EYE | 701 | 0.85% |
| INSOMNIA | 677 | 0.82% |
| PRODUCT DOSE OMISSION ISSUE | 671 | 0.81% |
| PYREXIA | 670 | 0.81% |
| CONFUSIONAL STATE | 661 | 0.80% |
| EYE DISORDER | 654 | 0.79% |
| DECREASED APPETITE | 627 | 0.76% |
| DEPRESSION | 625 | 0.76% |
| BACK PAIN | 611 | 0.74% |
| PRODUCT QUALITY ISSUE | 598 | 0.72% |
| CEREBROVASCULAR ACCIDENT | 585 | 0.71% |
| ACUTE KIDNEY INJURY | 583 | 0.71% |
| URINARY TRACT INFECTION | 571 | 0.69% |
| SOMNOLENCE | 568 | 0.69% |
| GAIT DISTURBANCE | 550 | 0.67% |
| ANAEMIA | 549 | 0.67% |
| INCORRECT DOSE ADMINISTERED | 534 | 0.65% |
| BLOOD PRESSURE INCREASED | 520 | 0.63% |
| ANXIETY | 516 | 0.63% |
| HYPOTENSION | 516 | 0.63% |
| FEELING ABNORMAL | 514 | 0.62% |
| CHEST PAIN | 512 | 0.62% |
| LACRIMATION INCREASED | 509 | 0.62% |
| ERYTHEMA | 499 | 0.60% |
| PALPITATIONS | 494 | 0.60% |
| ABDOMINAL DISCOMFORT | 488 | 0.59% |
| COVID-19 | 480 | 0.58% |
| BLINDNESS | 466 | 0.56% |
| MYALGIA | 463 | 0.56% |
| PERIPHERAL SWELLING | 450 | 0.55% |
| ATRIAL FIBRILLATION | 449 | 0.54% |
| PRODUCT USE ISSUE | 443 | 0.54% |
| ARTHRITIS | 439 | 0.53% |
| DRUG INTOLERANCE | 439 | 0.53% |
| MUSCLE SPASMS | 439 | 0.53% |
| NASOPHARYNGITIS | 433 | 0.52% |
| RENAL FAILURE | 432 | 0.52% |
| PRODUCT USE IN UNAPPROVED INDICATION | 429 | 0.52% |
| TREMOR | 429 | 0.52% |
| HAEMOGLOBIN DECREASED | 424 | 0.51% |
| OEDEMA PERIPHERAL | 420 | 0.51% |
| ABDOMINAL PAIN UPPER | 399 | 0.48% |
| ALOPECIA | 395 | 0.48% |
| ABDOMINAL PAIN | 393 | 0.48% |
| INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION | 392 | 0.48% |
| BRONCHITIS | 386 | 0.47% |
| DEHYDRATION | 384 | 0.47% |
| EYE SWELLING | 384 | 0.47% |
| WEIGHT INCREASED | 383 | 0.46% |
| MUSCULAR WEAKNESS | 379 | 0.46% |
| FOREIGN BODY SENSATION IN EYES | 362 | 0.44% |
| MYOCARDIAL INFARCTION | 361 | 0.44% |
| SYNCOPE | 360 | 0.44% |
| MEMORY IMPAIRMENT | 355 | 0.43% |
| DYSGEUSIA | 345 | 0.42% |
| WRONG TECHNIQUE IN PRODUCT USAGE PROCESS | 344 | 0.42% |
| BALANCE DISORDER | 343 | 0.42% |
| PARAESTHESIA | 342 | 0.41% |
| HYPOAESTHESIA | 340 | 0.41% |
| BLOOD GLUCOSE INCREASED | 339 | 0.41% |
| CARDIAC FAILURE CONGESTIVE | 336 | 0.41% |
| VERTIGO | 334 | 0.40% |
| ASTHMA | 332 | 0.40% |
| Total | 82508 | |